Literature DB >> 28209729

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.

Anthony P Carnicelli1, Raffaele De Caterina1, Jonathan L Halperin1, Giulia Renda1, Christian T Ruff1, Marco Trevisan1, Francesco Nordio1, Michele F Mercuri1, Elliott Antman1, Robert P Giugliano2.   

Abstract

Entities:  

Keywords:  anticoagulation; atrial fibrillation; bioprosthetic valve; edoxaban; warfarin

Mesh：

Substances：

Year:  2017        PMID： 28209729     DOI： 10.1161/CIRCULATIONAHA.116.026714

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  22 in total

1.  Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing.

Authors:  Jared P Beller; Elizabeth D Krebs; Robert B Hawkins; J Hunter Mehaffey; Mohammed A Quader; Alan M Speir; Andy C Kiser; Mark Joseph; Leora T Yarboro; Nicholas R Teman; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2019-09-28       Impact factor: 5.209

2.  Rivaroxaban in patients undergoing surgical mitral valve repair.

Authors:  Feridoun Noohi; Parham Sadeghipour; Sirous Kordrostami; Omid Shafe; Majid Maleki; Majid Kyavar; Hooman Bakhshandeh; Yousef Rezaei; Mehrad Rokni; Jamal Moosavi; Ahmad Amin; Ahmad Tashakori Beheshti; Saeid Hosseini
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

Review 3.  Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil.

Authors:  Renato D Lopes; Patricia O Guimarães; Elaine Hylek; Gilson S Feitosa-Filho; Luiz Ritt; Nivaldo Filgueiras; Eduardo Darzé; Mario S Rocha; Luis P Magalhães; Antonio Carlos Sobral Sousa; Luis Claudio Correia; Lucas Hollanda Oliveira; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

4.  An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve.

Authors:  Yalin Cao; Yuxiang Zheng; Siyuan Li; Fuwei Liu; Zhengbiao Xue; Kang Yin; Jun Luo
Journal:  Front Cardiovasc Med       Date:  2022-06-17

Review 5.  Anticoagulation Management After Transcatheter and Surgical Valve Replacement.

Authors:  Ricardo Cigarroa; Sammy Elmariah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-11

Review 6.  Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.

Authors:  Arnaud Bisson; Denis Angoulvant; Raphael Philippart; Nicolas Clementy; Dominique Babuty; Laurent Fauchier
Journal:  Adv Ther       Date:  2017-05-10       Impact factor: 3.845

7.  Intracardiac thrombus in a patient with mitral bioprosthesis and atrial fibrillation treated with direct oral anticoaugulant: A case report.

Authors:  Myriam D'Angelo; Roberta Manganaro; Ilaria Boretti; Daniele Giacopelli; Gaetano Cannavà; Francesco Corallo; Placido Bramanti; Antonio Duca
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

8.  Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review.

Authors:  Hannah Brokmeier; Kazuhiko Kido
Journal:  Ann Pharmacother       Date:  2020-11-04       Impact factor: 3.463

9.  Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.

Authors:  Ashwin S Nathan; Lin Yang; Zhi Geng; Elias J Dayoub; Sameed Ahmed M Khatana; Paul N Fiorilli; Howard C Herrmann; Wilson Y Szeto; Pavan Atluri; Michael A Acker; Nimesh D Desai; David S Frankel; Francis E Marchlinski; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld
Journal:  Am Heart J       Date:  2020-10-24       Impact factor: 5.099

10.  2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

Authors:  Chern-En Chiang; Ken Okumura; Shu Zhang; Tze-Fan Chao; Chung-Wah Siu; Toon Wei Lim; Anil Saxena; Yoshihide Takahashi; Wee Siong Teo
Journal:  J Arrhythm       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.